CY1112212T1 - NEW VEGETABLE FORMATS OF VOLUME CONNECTED WITH PARTICULARS OF ANTI-HUMAN LEVEL CELLS (HLA) CLASS I OR II - Google Patents
NEW VEGETABLE FORMATS OF VOLUME CONNECTED WITH PARTICULARS OF ANTI-HUMAN LEVEL CELLS (HLA) CLASS I OR IIInfo
- Publication number
- CY1112212T1 CY1112212T1 CY20121100003T CY121100003T CY1112212T1 CY 1112212 T1 CY1112212 T1 CY 1112212T1 CY 20121100003 T CY20121100003 T CY 20121100003T CY 121100003 T CY121100003 T CY 121100003T CY 1112212 T1 CY1112212 T1 CY 1112212T1
- Authority
- CY
- Cyprus
- Prior art keywords
- hla
- class
- particulars
- formats
- level cells
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
Η παρούσα εφεύρεση αφορά νέα σκευάσματα πεπτιδίων που σχετίζονται με όγκους τα οποία συνδέονται σε μόρια του αντιγόνου ανθρώπινων λευκοκυττάρων (HLA) Τάξης I ή II ως εμβόλια για χρήση σε ανοσοθεραπευτικές μεθόδους. Συγκεκριμένα, η παρούσα εφεύρεση σχετίζεται με σκευάσματα για την ανοσοθεραπεία του καρκίνου, και συγκεκριμένα καρκίνο του νεφρού και του εγκεφάλου, και συγκεκριμένα γλοίωμα, ειδικότερα γλοιοβλάστωμα καρκίνου. Η παρούσα εφεύρεση αφορά επιπλέον συνθέσεις εμβολίων για να επιφέρουν αντικαρκινικές ανοσοαπαντήσεις.The present invention relates to novel formulations of tumor-associated peptides that bind to Class I or II human leukocyte antigen (HLA) molecules as vaccines for use in immunotherapeutic methods. In particular, the present invention relates to formulations for cancer immunotherapy, in particular kidney and brain cancer, and in particular glioma, in particular glioblastoma of cancer. The present invention relates to further vaccine compositions to induce anti-cancer immune responses.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4766908P | 2008-04-24 | 2008-04-24 | |
EP08008292A EP2113253B1 (en) | 2008-04-30 | 2008-04-30 | Novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules for vaccines |
EP09005725A EP2111867B1 (en) | 2008-04-24 | 2009-04-23 | Novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules for vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1112212T1 true CY1112212T1 (en) | 2015-12-09 |
Family
ID=47785995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20121100003T CY1112212T1 (en) | 2008-04-24 | 2012-01-03 | NEW VEGETABLE FORMATS OF VOLUME CONNECTED WITH PARTICULARS OF ANTI-HUMAN LEVEL CELLS (HLA) CLASS I OR II |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP5921395B2 (en) |
CY (1) | CY1112212T1 (en) |
HK (1) | HK1223290A1 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102416176A (en) * | 1995-07-27 | 2012-04-18 | 基因技术股份有限公司 | Stabile isotonic lyophilized protein formulation |
AU2004229458B2 (en) * | 2003-04-11 | 2009-11-19 | Antigenics, Inc. | Improved heat shock protein-based vaccines and immunotherapies |
AR048098A1 (en) * | 2004-03-15 | 2006-03-29 | Wyeth Corp | CALIQUEAMYCIN CONJUGATES |
SI1760089T1 (en) * | 2005-09-05 | 2009-12-31 | Immatics Biotechnologies Gmbh | Tumor-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules and related anti-cancer vaccine |
PL2113253T3 (en) * | 2008-04-30 | 2010-09-30 | Immatics Biotechnologies Gmbh | Novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules for vaccines |
-
2012
- 2012-01-03 CY CY20121100003T patent/CY1112212T1/en unknown
- 2012-09-12 JP JP2012200596A patent/JP5921395B2/en not_active Expired - Fee Related
-
2016
- 2016-10-05 HK HK16111596.7A patent/HK1223290A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2013028621A (en) | 2013-02-07 |
HK1223290A1 (en) | 2017-07-28 |
JP5921395B2 (en) | 2016-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1110178T1 (en) | NEW VEGETABLE PEPPER CONNECTIONS CONCLUDED IN PARTICULARS OF HLA LEVEL I OR I | |
CY1119739T1 (en) | Innovative Immunotherapy Against Brain Tumors | |
CY1118702T1 (en) | COMPOSITION OF VOLUMES CONCERNING VOLUME AND RELATED Cancer Vaccine for Glioblastoma Therapy (GLIOBLASTOMA, GBM) | |
CY1115999T1 (en) | NEW AND POWERFUL MHC-CATEGORY II PURPOSES FROM SURBIVIN AND NEUROCANE | |
CY1113062T1 (en) | TUMORS RELATED TO TUMORS CONNECTED WITH PARTICULARS OF HUMAN LEVEL CELLS (HLA) CLASS I OR II AND RELATED ANTIQUES | |
MD3331900T2 (en) | Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers | |
CY1110051T1 (en) | TUMORS RELATED TO TUMORS CONNECTED IN PARTICULARS OF THE HLA CLASS II ANTI-HUMAN ANTIGEN | |
CY1117115T1 (en) | Innovative Immunotherapy Against Tumors And Neurons Of The Brain | |
CY1119941T1 (en) | STABLE AND SOLUBLE PARTS | |
MD3319985T2 (en) | Novel peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers | |
CY1124847T1 (en) | NOVEL PEPTIDES AND PEPTIDE COMBINATIONS FOR USE IN IMMUNOTHERAPY AGAINST HEPATO CELL CARCINOMA (HCC) AND OTHER CANCER | |
UA104572C2 (en) | Novel formulations of tumour-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules for vaccines | |
CY1112212T1 (en) | NEW VEGETABLE FORMATS OF VOLUME CONNECTED WITH PARTICULARS OF ANTI-HUMAN LEVEL CELLS (HLA) CLASS I OR II | |
CY1116819T1 (en) | Innovative Immunotherapy Against Different Tumors Including Gastrointestinal and Gastric Cancer |